Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

VK2735

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

Viking Therapeutics · Phase 3 · Active, not recruiting · Enrollment 1100

NCT07104383

ArmPopulationDoseWeeksEstimandWeight change
Placebo AssignmentObesity or overweightn/rn/rn/rn/r
Active Assignment (Dose #1)Obesity or overweightn/rn/rn/rn/r
Active Assignment (Dose #2)Obesity or overweightn/rn/rn/rn/r
Active Assignment (Dose #3)Obesity or overweightn/rn/rn/rn/r